Back to results

Novel melanoma antigens

The invention relates to melanoma antigen named MELOE and their use for preventing, treating and diagnosing melanoma.
More information (PDF)
Keywords: Melanoma, antigen, peptide, MELOE-1, MELOE-2
Patent Application number: European Procedure (Patents) (EPA) - 02 Sept. 2008 - 08 305 517.8
Inventors:
MOREAU-AUBRY AgnèsGODET Yann
Publications:
Oncoimmunology 2019 : Cancer Vaccines: Designing Artificial Synthetic Long Peptides to Improve Presentation of Class I and Class II T Cell Epitopes by Dendritic CellsJ Exp Med. 2008 205 (11) 2673-82Cancer Immunol Immunother 2011 60 (3) 327-37 Eur. J. Immunol. 2010. 40: 1786–94 PLoS One. 2013; 8(9): e75421

Reference:

BIO08305-T1

    Business Developper
    contact
    Aymeric Empereur
    Business Developer
    Patent filling date: 02-09-2008
    Rare disease: No
    Second indication: No

    You might also be interested in